Skip to main content
In stock|Targeted Therapy (Investigational)

NX-5948 (BTK Degrader)

Oncology TypeHematologic
Drug Class / MechanismTargeted Protein Degrader
No Image
Description

NX-5948 (BTK Degrader) is classified as a Targeted Protein Degrader, sourced for use within our Targeted Therapy (Investigational) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy (Investigational)
Oncology TypeHematologic

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3